Thursday, August 21st21.9°C
21790
21626

Sterigenics raises offer for Nordion to US$805 million or US$13 per share

OTTAWA - Medical isotope supplier Nordion Inc. (TSX:NDN) said Monday that Sterigenics has raised its takeover offer to US$805 million after an earlier offer failed to garner enough shareholder support.

The bid of $13 per share is up from $12.25 per share and the second increase to the offer, which began at $11.75.

Shareholders were to vote on the earlier offer last week, but the meeting was postponed after it became apparent the deal wouldn't receive the required two-thirds majority approval.

"Although a clear majority of Nordion shareholders supported Sterigenics’ all-cash acquisition proposal at US$12.25 per share, there did not appear to be sufficient shareholder support to approve the transaction," the company said in a statement.

Shareholders are expected to vote Friday on the new offer by Sterigenics, an affiliate of Chicago-based private equity firm GTCR LLC.

Nordion is a leading suppliers of medical isotopes, used for certain types of medical imaging. It also provides sterilization technologies for several industries.

The new offer follows an unsolicited offer of $12.50 last week from an unidentified third party that had earlier made an offer of US$12.25, Nordion said.

Nordion also reported Monday that it had a second-quarter profit of $6.7 million or 11 cents per share, up from a profit of $731,000 or a penny per share a year ago.

Revenue for the quarter ended April 30 totalled $74.7 million, up from $56.1 million in the same three months a year earlier.

On an adjusted basis, Nordion said it earned $13.5 million or 22 cents per share for the quarter, up from $4.8 million or eight cents per share in the second quarter last year.

The company settled a bitter legal fight with Atomic Energy of Canada Ltd. last year with a new supply deal that will run until October 2016 and an agreement by both sides to drop more than $100 million in claims.

A shortage of medical isotopes occurred around the world when AECL's NRU reactor was shut down in 2009 because of a leak that took more than a year to repair.

The shortage raised concerns about the availability of medical tests and Ottawa's decision to end the Maple program, an over-budget-and-behind-schedule plan to replace the NRU reactor.

The Canadian Press


Read more Business News

17772


Recent Trending




Today's Market
S&P TSX15564.33+2.38
S&P CDNX995.42-1.28
DJIA17040.2061.07
Nasdaq4532.104+5.623
S&P 5001992.35+5.84
CDN Dollar0.9137+0.0022
Gold1273.80-19.60
Oil96.30+1.82
Lumber356.10+1.10
Natural Gas3.879+0.056

 
Okanagan Companies
Pacific Safety0.18-0.005
Knighthawk0.01-0.005
QHR Technologies Inc1.20-0.01
Cantex0.065-0.005
Anavex Life Sciences0.260.00
Metalex Ventures0.075-0.01
Russel Metals37.55+0.10
Copper Mountain Mining2.90-0.02
Colorado Resources0.175-0.01
ReliaBrand Inc0.095+0.01
Sunrise Resources Ltd0.025-0.005
Mission Ready Services0.215-0.015

 



21623

FEATURED Property
1973251389 Adamson Drive
4 bedrooms 3 baths
$625,000
more details
image2image2image2
Click here to feature your property
Please wait... loading


Joint accounts: what you need to know!

Establishing a joint account may seem like a great strategy at first glance. However, there are many factors that must be considered before taking this action. This article will explore the use of &ls...


Cost of an Injury Lawyer

Let’s face it; nobody wants to pay for legal services if they do not have to, but if you have been injured in an accident you may have thought about hiring a lawyer to help you navigate your cla...


Going home to a bully!

Finally, after three months in New Brunswick, I am back home in the sunny Okanagan. It is a delight to be home and the lake, vistas, people and climate never disappoint. Like many people however, I...

_








Member of BC Press Council


22717